Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3‐L1 adipocytes and HepG2 hepatocytes
Open Access
- 15 February 2002
- journal article
- Published by Wiley in FEBS Letters
- Vol. 514 (2-3) , 315-322
- https://doi.org/10.1016/s0014-5793(02)02390-6
Abstract
Several herbal medicines improve hyperlipidemia, diabetes and cardiovascular diseases. However, the molecular mechanism underlying this improvement has not yet been clarified. In this study, we found that several isoprenols, common components of herbal plants, activate human peroxisome proliferator‐activated receptors (PPARs) as determined using the novel GAL4 ligand‐binding domain chimera assay system with coactivator coexpression. Farnesol and geranylgeraniol that are typical isoprenols in herbs and fruits activated not only PPARγ but also PPARα as determined using the chimera assay system. These compounds also activated full‐length human PPARγ and PPARα in CV1 cells. Moreover, these isoprenols upregulated the expression of some lipid metabolic target genes of PPARγ and PPARα in 3T3‐L1 adipocytes and HepG2 hepatocytes, respectively. These results suggest that herbal medicines containing isoprenols with dual action on both PPARγ and PPARα can be of interest for the amelioration of lipid metabolic disorders associated with diabetes.Keywords
This publication has 37 references indexed in Scilit:
- Identification of Peroxisome Proliferator-responsive Human Genes by Elevated Expression of the Peroxisome Proliferator-activated Receptor α in HepG2 CellsJournal of Biological Chemistry, 2001
- Peroxisome Proliferator–Activated Receptor γ and Metabolic DiseaseAnnual Review of Biochemistry, 2001
- Peroxisome Proliferator-activated Receptor δ (PPARδ)-mediated Regulation of Preadipocyte Proliferation and Gene Expression Is Dependent on cAMP SignalingJournal of Biological Chemistry, 2001
- p300 Interacts with the N- and C-terminal Part of PPARγ2 in a Ligand-independent and -dependent Manner, RespectivelyPublished by Elsevier ,1999
- Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARγ ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cellsLife Sciences, 1998
- p300 Functions as a Coactivator for the Peroxisome Proliferator-activated Receptor αJournal of Biological Chemistry, 1997
- The Antidiabetic Agent Thiazolidinedione Stimulates the Interaction between PPARγ and CBPBiochemical and Biophysical Research Communications, 1997
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994